The Political-Economy of ASEAN-China Free Trade Agreement - An Indonesian Perspective

Author(s):  
Ignatius Ismanto ◽  
Indra Khrisnamurti
1993 ◽  
Vol 25 (2) ◽  
pp. 27-35 ◽  
Author(s):  
Fred O. Boadu ◽  
Maria R. Thompson

AbstractThis paper presents an empirical analysis of the strategic forces shaping U.S.-Mexico trade relationships and the possibilities of extending the trade agreement to the rest of the Americas. The paper concludes that constituency interests, party loyalty, the proportion of a state's population of Hispanic origin, and the influence of textile-related employment in the state were significant explanatory factors in the Congressional Fast Track vote that occurred in May of 1991.


PMLA ◽  
1999 ◽  
Vol 114 (3) ◽  
pp. 311-317 ◽  
Author(s):  
Linda Hutcheon

In 1988, in the midst of the often acrimonious debates about the North American Free Trade Agreement, a button began to appear on Canadian lapels. It featured a section of the Stars and Stripes with a red maple leaf in the place of one star, and a caption read, “No, eh.” Through this image, the anti-free-trade side offered parodic resistance to what it saw as the assimilation—not to say wholesale economic engulfing—of Canada by the United States. Typically self-deprecatory, Canadian humor demanded that the rejection be couched in a gentle mocking of the national verbal tic: eh? is the terser but less elegant Canadian version of the French n'est-ce pas? and the German nicht wahr? In some ways the intellectual equivalent of NAFTA, the MLA is much older than the economic institution and somewhat less controversial. Nevertheless, it too is not unproblematic for Canadians, and to see why and how, one needs to understand something of the political and cultural relations between a very small and a very large nation when they adjoin.


2004 ◽  
Vol 28 (2) ◽  
pp. 218 ◽  
Author(s):  
Ken Harvey

There is tension between the need of the pharmaceutical innovator for intellectual property protection and the need of society for equitable and affordable access to innovative drugs. The recent Australia?United States Free Trade Agreement provides a nice illustration of this interplay between patents, pills and politics. This article provides a brief history of patent law as applied to pharmaceuticals, describes how the Pharmaceutical Benefits Scheme got caught up in AUSFTA negotiations, analyses the clauses that are likely to impact upon the PBS and describes the political process that reviewed and ultimately amended the AUSFTA.


Sign in / Sign up

Export Citation Format

Share Document